DE69606677T2 - Eine Trifluormethylsulfonylphenyl- oder Trifluormethylsulfinylphenylgruppe enthaltende 2-Cyan-3-hydroxy-propenamidderivate, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen - Google Patents

Eine Trifluormethylsulfonylphenyl- oder Trifluormethylsulfinylphenylgruppe enthaltende 2-Cyan-3-hydroxy-propenamidderivate, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE69606677T2
DE69606677T2 DE69606677T DE69606677T DE69606677T2 DE 69606677 T2 DE69606677 T2 DE 69606677T2 DE 69606677 T DE69606677 T DE 69606677T DE 69606677 T DE69606677 T DE 69606677T DE 69606677 T2 DE69606677 T2 DE 69606677T2
Authority
DE
Germany
Prior art keywords
cyano
hydroxy
trifluoromethylsulfonylphenyl
medicaments
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69606677T
Other languages
English (en)
Other versions
DE69606677D1 (de
Inventor
David Paul Kay
Elizabert Anne Kuo
Richard Alexander Williamson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of DE69606677D1 publication Critical patent/DE69606677D1/de
Application granted granted Critical
Publication of DE69606677T2 publication Critical patent/DE69606677T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/40—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69606677T 1995-10-02 1996-10-01 Eine Trifluormethylsulfonylphenyl- oder Trifluormethylsulfinylphenylgruppe enthaltende 2-Cyan-3-hydroxy-propenamidderivate, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen Expired - Fee Related DE69606677T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9520092.9A GB9520092D0 (en) 1995-10-02 1995-10-02 Chemical compounds

Publications (2)

Publication Number Publication Date
DE69606677D1 DE69606677D1 (de) 2000-03-23
DE69606677T2 true DE69606677T2 (de) 2000-08-17

Family

ID=10781638

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69606677T Expired - Fee Related DE69606677T2 (de) 1995-10-02 1996-10-01 Eine Trifluormethylsulfonylphenyl- oder Trifluormethylsulfinylphenylgruppe enthaltende 2-Cyan-3-hydroxy-propenamidderivate, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen

Country Status (10)

Country Link
US (1) US5693844A (de)
EP (1) EP0767167B1 (de)
JP (1) JPH09132559A (de)
AT (1) ATE189810T1 (de)
DE (1) DE69606677T2 (de)
DK (1) DK0767167T3 (de)
ES (1) ES2143159T3 (de)
GB (1) GB9520092D0 (de)
GR (1) GR3033175T3 (de)
PT (1) PT767167E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325380A (zh) * 1998-09-11 2001-12-05 味之素株式会社 苯衍生物和它们的药物用途
US8686048B2 (en) 2010-05-06 2014-04-01 Rhizen Pharmaceuticals Sa Immunomodulator and anti-inflammatory compounds
US20140031383A1 (en) 2011-02-08 2014-01-30 Dana-Farber Cancer Institute, Inc. Methods for treatment of melanoma
TN2016000197A1 (en) 2013-11-22 2017-10-06 Genzyme Corp Novel methods for treating neurodegenerative diseases.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1116382B (it) * 1977-11-30 1986-02-10 Sigma Tau Ind Farmaceuti Metodo di preparazione industriale dell'acido rs-beta-benzoilamino isobutirrico
IT1097280B (it) * 1978-06-26 1985-08-31 Montedison Spa Pigmenti bismetinici
US4710514A (en) * 1982-05-04 1987-12-01 Sumitomo Chemical Company, Limited Fungicidal carbamates and thiolcarbamates
US4946867A (en) * 1987-09-07 1990-08-07 Sumitomo Chemical Company, Limited Cyanoacetamide derivative, and plant disease protectant comprising the same as an active ingredient
DK0527736T3 (da) * 1990-05-18 1997-10-20 Hoechst Ag Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler.
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds

Also Published As

Publication number Publication date
DK0767167T3 (da) 2000-07-24
EP0767167A1 (de) 1997-04-09
JPH09132559A (ja) 1997-05-20
DE69606677D1 (de) 2000-03-23
GR3033175T3 (en) 2000-08-31
EP0767167B1 (de) 2000-02-16
ATE189810T1 (de) 2000-03-15
GB9520092D0 (en) 1995-12-06
US5693844A (en) 1997-12-02
PT767167E (pt) 2000-06-30
ES2143159T3 (es) 2000-05-01

Similar Documents

Publication Publication Date Title
DE69300532T2 (de) Naphtylalkylamine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE59204094D1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien.
ATE170510T1 (de) 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
ATE94869T1 (de) Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika.
DE69132167T2 (de) Kondensierte benzoxa-ringverbindung, deren herstellung sowie diese enthaltendes arzneimittel
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FR2707085B1 (fr) Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE69424734T2 (de) Phenyl-Carboxamide-Isoxazole-Derivate und Salze, Verfahren zu ihrer Herstellung ihre Anwendung als Arzneimittel und pharmazeutische Zusammensetzungen die sie enthalten
DE69606677D1 (de) Eine Trifluormethylsulfonylphenyl- oder Trifluormethylsulfinylphenylgruppe enthaltende 2-Cyan-3-hydroxy-propenamidderivate, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen
DE69321861D1 (de) 3-Aminochroman-Spiroderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69400024D1 (de) 2-Cyano-2-hydroxypropenamidederivate, Verfahren zu ihrer Herstellung ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen.
DE69120699T2 (de) N-Monosubstituierte Cyclopentenylamine, ein Verfahren zu ihrer Herstellung, und ihre Verwendung als Medikament
DE3887102T2 (de) Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen.
ATE86993T1 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE69305330T2 (de) Aminoalkylchomone, Verfahren für ihre Herstellung und die enthaltende pharmazeutische Zusammensetzungen
ATE97130T1 (de) 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln.
DE69322218D1 (de) Heteroarenylpiperazine, Verfahren zu ihrer Herstellung und ihre Anwendung als Medikamente
DE69400283T2 (de) (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
TH17047A (th) อนุพันธ์ของ n-ซับสทิทิวเทด อะซาไบไซโคลเฮพเทน, การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
DE59301096D1 (de) Arzneimittel enthaltend 1,5,6,7-Tetrahydro-4H-indazol-4-one, neue 1,5,6,7-Tetrahydro-4H-indazol-4-one und verfahren zu ihrer Herstellung.
DE59008807D1 (de) Imidazolylpropylguanidinderivat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY CEDEX, FR

8339 Ceased/non-payment of the annual fee